Primary Care–Based Models for the Treatment of Opioid Use Disorder
Top Cited Papers
- 6 December 2016
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 166 (4), 268-278
- https://doi.org/10.7326/m16-2149
Abstract
Greater integration of medication-assisted treatment (MAT) for opioid use disorder (OUD) in U.S. primary care settings would expand access to treatment for this condition. Models for integrating MAT into primary care vary in structure. This article summarizes findings of a technical report for the Agency for Healthcare Research and Quality describing MAT models of care for OUD, based on a literature review and interviews with key informants in the field. The report describes 12 representative models of care for integrating MAT into primary care settings that could be considered for adaptation across diverse health care settings. Common components of existing care models include pharmacotherapy with buprenorphine or naltrexone, provider and community education, coordination and integration of OUD treatment with other medical and psychological needs, and psychosocial services and interventions. Models vary in how each component is implemented. Decisions about adopting MAT models of care should be individualized to address the unique milieu of each implementation setting.Keywords
Funding Information
- Agency for Healthcare Research and Quality (Contract No. HHSA290201500009I, Task Order Number 4)
This publication has 43 references indexed in Scilit:
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using BuprenorphineJAMA Internal Medicine, 2011
- Improving Adherence to HIV Quality of Care Indicators in Persons With Opioid Dependence: The Role of BuprenorphineJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- The Cost of Integrated HIV Care and Buprenorphine/Naloxone Treatment: Results of a Cross-Site EvaluationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/NaloxoneJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV ClinicsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureThe New England Journal of Medicine, 2010
- Patients' Reasons for Choosing Office-Based Buprenorphine: Preference for Patient-Centered CareJournal of Addiction Medicine, 2010
- A Transitional Opioid Program to Engage Hospitalized Drug UsersJournal of General Internal Medicine, 2010
- Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based SettingJournal of General Internal Medicine, 2007